Obamacare's Medical-Device Excise Tax: Early Evidence Suggests Significant Harm

The medical-device industry’s primary lobbying goal this year is to repeal Obamacare’s 2.3 percent excise tax on medical devices. Device makers have been collecting and remitting this new tax since the beginning of 2013.

Now that we are in the second half of 2013, we can inquire whether the early evidence confirms these predictions. Preliminary research on the financial results for the first half of the year suggests that the excise tax is causing significant harm.

Read this entire article at Forbes.com's The Apothecary here.